Christine A Devlin

5PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical devicesMedical molecular engineering of nucleic acids and proteinsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2023
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes.

Yi Sun, Georgia F Papadaki, Christine A Devlin

|Sep 12, 2022
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2.

Lianghui Zhang, Krishna K Narayanan, Laura Cooper

|Jun 21, 2022
TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.

Andrew C McShan, Christine A Devlin, Georgia F Papadaki

|May 27, 2021
TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.

Andrew C McShan, Christine A Devlin, Giora I Morozov

|Oct 25, 2018
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses.

Eleanor Clancy-Thompson, Christine A Devlin, Paul M Tyler

Pageof 1

Frequent Collaborators

4 joint publications

Erik Procko

3 joint publications

Nikolaos G Sgourakis

2 joint publications

George M Burslem

1 joint publications

Lestat R Ali